On Tuesday, Abeona Therapeutics Inc (NASDAQ: ABEO) was 6.32% up from the session before settling in for the closing price of $4.59. A 52-week range for ABEO has been $3.93 – $7.54.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 47.21%. When this article was written, the company’s average yearly earnings per share was at 174.84%. With a float of $49.19 million, this company’s outstanding shares have now reached $52.40 million.
Abeona Therapeutics Inc (ABEO) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Abeona Therapeutics Inc stocks. The insider ownership of Abeona Therapeutics Inc is 9.22%, while institutional ownership is 62.41%. The most recent insider transaction that took place on Nov 13 ’25, was worth 71,168. In this transaction Director of this company sold 15,000 shares at a rate of $4.74, taking the stock ownership to the 62,252 shares. Before that another transaction happened on Nov 13 ’25, when Company’s Director proposed sale 15,000 for $4.74, making the entire transaction worth $71,168.
Abeona Therapeutics Inc (ABEO) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.32 earnings per share (EPS) during the time that was better than consensus figure (set at -0.34) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 174.84% per share during the next fiscal year.
Abeona Therapeutics Inc (NASDAQ: ABEO) Trading Performance Indicators
You can see what Abeona Therapeutics Inc (ABEO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 9.53. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 661.14.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.17, a number that is poised to hit -0.33 in the next quarter and is forecasted to reach -0.13 in one year’s time.
Technical Analysis of Abeona Therapeutics Inc (ABEO)
The latest stats from [Abeona Therapeutics Inc, ABEO] show that its last 5-days average volume of 1.78 million was superior to 1.18 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 50.06%.
During the past 100 days, Abeona Therapeutics Inc’s (ABEO) raw stochastic average was set at 24.86%, which indicates a significant decrease from 55.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.32 in the past 14 days, which was higher than the 0.28 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.07, while its 200-day Moving Average is $5.70. Now, the first resistance to watch is $4.99. This is followed by the second major resistance level at $5.10. The third major resistance level sits at $5.30. If the price goes on to break the first support level at $4.68, it is likely to go to the next support level at $4.49. The third support level lies at $4.38 if the price breaches the second support level.
Abeona Therapeutics Inc (NASDAQ: ABEO) Key Stats
There are 54,191K outstanding shares of the company, which has a market capitalization of 264.46 million. As of now, sales total 0 K while income totals -63,730 K. Its latest quarter income was 400 K while its last quarter net income were 108,830 K.
